Correction to: Implications of Individual QT/RR Profiles—Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections

Marek Malik (), Christine Garnett, Katerina Hnatkova, Jose Vicente, Lars Johannesen and Norman Stockbridge
Additional contact information
Marek Malik: National Heart and Lung Institute, Imperial College
Christine Garnett: US Food and Drug Administration
Katerina Hnatkova: National Heart and Lung Institute, Imperial College
Jose Vicente: US Food and Drug Administration
Lars Johannesen: US Food and Drug Administration
Norman Stockbridge: US Food and Drug Administration

Drug Safety, 2019, vol. 42, issue 3, No 12, 473-473

Abstract: The Open Access license, which previously read:

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-019-00801-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-019-00801-w

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-019-00801-w

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().